Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem Cell Transplantation in Patients with Malignant Lymphoma

BACKGROUND: The aim of this study was to compare nutrition-related adverse events and clinical outcomes of ifosfamide, carboplatin, and etoposide regimen (ICE therapy) and ranimustine, carboplatin, etoposide, and cyclophosphamide regimen (MCEC therapy) instituted as pretreatment for autologous perip...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoyama, Takashi, Imataki, Osamu, Arai, Hidekazu, Kume, Tetsuo, Shiozaki, Hitomi, Katsumata, Naomi, Mori, Mariko, Ishide, Keiko, Ikeda, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Human Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810616/
https://www.ncbi.nlm.nih.gov/pubmed/29398693
http://dx.doi.org/10.12659/MSMBR.908113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810616/
https://www.ncbi.nlm.nih.gov/pubmed/29398693
http://dx.doi.org/10.12659/MSMBR.908113

Ejemplares similares